Yahoo Poland Wyszukiwanie w Internecie

Search results

1. www.idsociety.org › practice-guideline › amr-guidanceIDSA 2024 Guidance on the Treatment of Antimicrobial Resistant...

   www.idsociety.org › practice-guideline › amr-guidance

   • Zapisane w pamięci cache

   12 lip 2024 · This guidance document provides recommendations to clinicians for treatment of infections caused by extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and difficult-to-treat Pseudomonas aeruginosa (DTR-P. aeruginosa).

   • Infection Prevention & Control

     IDSA/SHEA: Primer on Healthcare Epidemiology, Infection...

   • Guideline Development Process

     Because of the large number of clinical practice guidelines...

   • Ebola

     What is Ebola? Ebola virus disease is a severe illness that...

   • Evaluation and Management Services

     Dr. Timothy Sullivan, Vice Chair of IDSA’s Coding & Payment...

   • Bio-Preparedness Workforce Pilot

     On Thursday, June 15, in Washington, D.C., Axios health care...

   • Lyme Disease

     lyme disease; tick borne disease. Lyme disease, caused by...

   • ID Match

     The IDSA ID Match Resolution provides guiding principles for...

   • Hepatitis C

     Viral hepatitis is a silent epidemic. According to the...

2. www.who.int › news-room › fact-sheetsAntimicrobial resistance - World Health Organization (WHO)

   www.who.int › news-room › fact-sheets

   • Zapisane w pamięci cache

   21 lis 2023 · The 2022 Global Antimicrobial Resistance and Use Surveillance System (GLASS) report highlights alarming resistance rates among prevalent bacterial pathogens. Median reported rates in 76 countries of 42% for third-generation cephalosporin-resistant E. coli and 35% for methicillin-resistant Staphylococcus aureus are a major concern.

3. www.ecdc.europa.eu › en › antimicrobial-resistanceAntimicrobial resistance (AMR) - European Centre for Disease...

   www.ecdc.europa.eu › en › antimicrobial-resistance

   • Zapisane w pamięci cache

   Brief: Antimicrobial resistance targets - how can we reach them by 2030? Each year throughout the EU, Iceland and Norway, more than 35 000 people die from infections with bacteria that are resistant to antimicrobials.

4. www.ema.europa.eu › public-health-threats › antimicrobial-resistanceAntimicrobial resistance | European Medicines Agency (EMA)

   www.ema.europa.eu › public-health-threats › antimicrobial-resistance

   • Zapisane w pamięci cache

   Antimicrobial resistance is when a microbe evolves to become more or fully resistant to antimicrobials which previously could treat it. Antimicrobials include antibiotics, which kill or inhibit the growth of bacteria.

5. health.ec.europa.eu › antimicrobial-resistance › eu-action-antimicrobial-resistance_enEU Action on Antimicrobial Resistance - European Commission -...

   health.ec.europa.eu › antimicrobial-resistance › eu-action-antimicrobial-resistance_en

   • Zapisane w pamięci cache

   strengthen infection prevention and control. strengthen antimicrobial stewardship and prudent use of antimicrobials. recommend targets for AMR and antimicrobial consumption in human health. improve awareness, education and training.

6. www.ecdc.europa.eu › antimicrobial-resistance-strategiesStrategies and action plans on antimicrobial resistance

   www.ecdc.europa.eu › antimicrobial-resistance-strategies

   • Zapisane w pamięci cache

   19 lut 2024 · Antimicrobial resistance – knowledge gaps, challenges and relevant measures. Status 2020 (Norwegian Institute of Public Health, 2020) Antibiotikaresistens - Kunnskapshull, utfordringer og aktuelle tiltak.

7. integ.idsociety.org › practice-guideline › amr-guidanceIDSA 2023 Guidance on the Treatment of Antimicrobial Resistant...

   integ.idsociety.org › practice-guideline › amr-guidance

   • Zapisane w pamięci cache

   This guidance document provides recommendations to clinicians for treatment of infections caused by extended-spectrum β-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and difficult-to-treat Pseudomonas aeruginosa (DTR-P. aeruginosa).